US Department of Health and Human Services and SAMHSA's National Clearinghouse For Alcohol and Drug Information DHHS SAMHSA's National Clearinghouse For Alcohol and Drug Information
Photo Of Person One Photo Of Person Two Photo Of Person Three Photo Of Person Four
Drugs
Audiences
Issues
Publications
Newsroom
Calendar
Resources
Research

This Web site is a component of the SAMHSA Health Information Network.

Publications
Publications

Quick Find & Order
Top 50
Pubs in Series
Posters
Videos
Spanish
Drugs
Audiences
Issues

This Web site is a component of the SAMHSA Health Information Network.

  

Treatment Drug Courts: Integrating Substance Abuse Treatment With Legal Case Processing
Treatment Improvement Protocol (TIP) Series 23

Exhibits

Exhibit 1-1 Examples of Systems Integration

In the District of Columbia and Multnomah County, Oregon, "supervised release" or "conditional release mechanisms" operate to release defendants from pretrial custody under conditions that include regular or random urine testing, graduated sanctions, and participation in a substance abuse treatment program."
The Dade County, Florida, program involves acceptance into a drug court treatment program shortly after arrest, with an understanding that further prosecution will be held in abeyance, and if the defendant successfully completes the program, the charges will be dropped.
Pensacola, Florida has a "deferred judgment" program or "post-plea diversion" program shortly after arrest, under which the defendant pleads guilty to a criminal charge (for example, unlawful possession of drugs) with the understanding that sentence will be deferred. If the defendant successfully completes the program, the plea of guilty will be vacated and the charges dropped, but if the defendant fails to complete the program, sentence will be based on the original charge.

Exhibit 2-1 Traditional Court Characteristics Versus Drug Court Characteristics

Traditional CourtDrug Court
Court team of judge, prosecutor, defense counsel, etcNew court team created to achieve goals of supportive treatment interventions
AdversarialNon-adversarial
Goal = Process case; apply the lawGoal = Restore defendant as a productive, non-criminal member of society
Judge exercises limited role in supervision of defendantJudge plays central role in monitoring defendant's progress in treatment
Interventions for substance abuse at discretion of judgeFormalized and structured treatment interventions
Relapse may lead to increased sentence Graduated sanctions used to respond to lapses in drug court program conditions

Exhibit 8-1 Consent for the Release of Confidential Information

Exhibit 8-1
Consent for the Release of Confidential Information:
Criminal Justice System Referral
I, ____________________________________________________
(Name of defendant),
hereby consent to communication between ________________________________
									   (treatment program)
and______________________________________________________
(Court, probation, parole, and/or other referring agency)
the following information:

____________________________________________________________
(Nature of the information, as limited as possible)

The purpose of and need for the disclosure is to inform the criminal justice agencies listed above of my attendance and progress in treatment. The extent of information to be disclosed is my diagnosis, information about my attendance or lack of attendance at treatment sessions, my cooperation with the treatment program, prognosis, and I understand that this consent will remain in effect and cannot be revoked by me until:
There has been a formal and effective termination or revocation of my release from confinement, probation, or parole, or other proceeding under which I was mandated into treatment, or

(other time when consent can be revoked and/or expires)
I also understand that any disclosure made is bound by Part 2 of Title 42 of the Code of Federal Regulations governing confidentiality of alcohol and drug abuse patient records and that recipients of this information may re-disclose it only in connection with their official duties.
(Date)(Signature of defendant/patient)
(Signature of parent, guardian, guardian, or authorized representative if required)

Exhibit 8-2 Prohibition on Re-disclosing Information

Prohibition on Re-disclosing Information
Concerning AOD Abuse Treatment Patients
This notice accompanies a disclosure of information concerning a client in alcohol/drug abuse treatment, made to you with the consent of such client. This information has been disclosed to you from records protected by Federal confidentiality rules (42 CFR Part 2). The Federal rules prohibit you from making any further disclosure of this information unless further disclosure is expressly permitted by the written consent of the person to whom it pertains or as otherwise permitted by 42 CFR Part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. The Federal rules restrict any use of the information to criminally investigate or prosecute any alcohol or drug abuse patient.

Exhibit 8-3 Consent for the Release of Confidential Information

Consent for the Release of Confidential Information
I, ______________________________________________________________________
   (Name of patient),
authorize _______________________________________________________________
         (Name or general designation of program making disclosure)
to disclose to __________________________________________________________________
              (Name of person or organization to which disclosure is to be made)
the following information:

________________________________________________________________________________
(Nature of the information, as limited as possible)

The purpose of the disclosure authorized herein is to:

________________________________________________________________________________
(Purpose of disclosure, as specific as possible)

I understand that my records are protected under the federal regulations governing Confidentiality of Alcohol and Drug Abuse Patient Records, 42 CFR Part 2, and cannot be disclosed without my written consent unless otherwise provided for in the regulations. I also understand that I may revoke this consent at any time except to the extent that action has been taken in reliance on it, and that in any event this consent expires automatically as follows: (Specification of the date, event, or condition upon which this consent expires)

(Date)(Signature of defendant/patient)
(Signature of parent, guardian, guardian, or authorized representative if required)
 



NCADI Live Help
Send this Page to a Friend E-mail this Page
Printer Friendly Version Print this Page
Join the eNetwork Join the eNetwork
Contact Us Contact Us
Link to Us Link to Us
Home Home

CSAPs Model Programs (new window)

Multimedia
 
Initiatives  |   Funding  |   Home
U.S. Department of Human and Health Services U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
Center for Mental Health Services
Center for Substance Abuse Prevention
Center for Substance Abuse Treatment
 
National Clearinghouse for Alcohol and Drug Information
About Us | Privacy | Accessibility | Disclaimer | Site Map | Awards |Customer Service
SAMHSA Home | Freedom of Information Act | Department of Health and Human Services | The White House | USA.gov